In a finding that feels equal parts hopeful and overdue, a new federally funded study has found that people who intentionally reach for cannabis to handle opioid withdrawal symptoms often end up using fewer unregulated opioids overall—and the effect is especially strong for those living with moderate or severe pain.
Researchers from the University of British Columbia, Simon Fraser University, and UCLA surveyed 197 people in Vancouver who use both cannabis and unregulated opioids like fentanyl or heroin. Nearly half of them (45.2%) said they had turned to marijuana specifically to manage withdrawal symptoms in the past six months. Of that group, two-thirds reported that when they used cannabis, they simply didn’t need as much of the opioids they were taking. After adjusting for age, gender, race, and pain levels, the team found that using cannabis for withdrawal management more than doubled the odds of reporting reduced opioid use. Among people dealing with moderate or severe pain, the association jumped even higher—more than six times the odds of cutting back.
“Cannabis use for opioid withdrawal was significantly associated with self-reported reductions in opioid use,” the researchers wrote in the Journal of Cannabis Research. They noted this appears to be the first quantitative look specifically at intentional cannabis use for withdrawal and its link to lower opioid consumption. The study, supported by both the U.S. National Institutes of Health and the Canadian Institutes of Health Research, ran from late 2019 into 2021. Overall, 57% of participants said they used fewer opioids during periods when they were consuming cannabis. The authors pointed out the obvious but important contrast: cannabis carries far lower risks of serious harm and death than unregulated opioids. They argued that expanding access to legal cannabis—particularly for people most at risk of overdose—could be a practical step toward reducing the damage of the opioid crisis. They also called for experimental trials to test cannabinoids more rigorously for people experiencing withdrawal and chronic pain.
This latest paper joins a growing pile of research suggesting cannabis can act as a harm-reduction tool. Other recent studies have linked medical and adult-use legalization to drops in opioid prescriptions, overdoses, and even payments from opioid manufacturers to pain doctors. One found “large, sustained” improvements in chronic lower back pain and near-total opioid cessation after patients switched to inhaled cannabis. Another showed daily cannabis use among people with chronic pain was tied to a higher chance of quitting opioids altogether. In short: for some people stuck in the brutal cycle of unregulated opioids and withdrawal, a plant that is increasingly legal and comparatively safer appears to be helping them dial down the harder stuff. The science is still observational and self-reported, but the signal keeps getting clearer—and more interesting.
